PN 76200
RN 00553 
AN 77038213
AU Wilson-G-B.  Burdash-N-M.  Arnaud-P.  Monsher-M-T.  Fudenberg-H-H.
TI Carcinoembryonic antigen and cystic fibrosis protein in blood from
   cystic fibrosis homozygotes and heterozygote carriers.
SO Scand-J-Immunol. 1976. 5(6-7). P 829-36.
MJ CARCINOEMBRYONIC-ANTIGEN.  CYSTIC-FIBROSIS: im.
MN ADOLESCENCE.  ADULT.  BLOOD-PROTEINS: an.  BLOOD-SPECIMEN-COLLECTION.
   CARCINOEMBRYONIC-ANTIGEN: an.  CARRIER-PROTEINS: an.  CHILD.
   CHILD-PRESCHOOL.  CYSTIC-FIBROSIS: bl, fg.
   GASTROINTESTINAL-NEOPLASMS: im.  GEL-DIFFUSION-TESTS.  HETEROZYGOTE.
   HOMOZYGOTE.  HUMAN.  ISOELECTRIC-FOCUSING.  RADIOIMMUNOASSAY.
   SUPPORT-U-S-GOVT-P-H-S.
AB Carcinoembryonic antigen (CEA) activity was measured by
   radioimmunoassay in blood from cystic fibrosis (CF) homozygotes,
   heterozygote carriers of CF, normal healthy controls, and other
   patient controls with carcinomas involving gastrointestinal organs.
   All samples were also screened by electrofocusing for cystic fibrosis
   protein (CFP), a metabolic marker previously shown to be associated
   with the CF gene. Significantly increased levels of CEA activity were
   found in all CFP-positive groups; however, with one exception all
   patient controls with marked increases in CEA activity were CFP-
   negative. Immunodiffusion of perchloric acid extracts of CEA-like
   material from heterozygote carrier blood indicated that the CEA-like
   material, which was elevated in homozygotes and heterozygotes for CF,
   showed only partial identity with two separate CEA preparations
   obtained from colon carcinomas and was not identical to either A, B,
   or O(H) blood group substances. This glycoprotein material did,
   however, react with three different anti-CEA antisera. Our finding of
   an abnormally increased glycoprotein in cystic fibrosis, taken
   together with previous reports demonstrating abnormalities in the
   carbohydrate portion of glycoproteins found in various  exocrine
   secretions in CF, further suggests that the primary defect in this
   disease is manifested partly as a defect in glycoprotein metabolism.
   This defect may result from an abnormality in one or more of the
   glycosyltransferases, possibly caused by a more primary defect in
   polyamine metabolism.
RF 001   ANDERSEN DH           ANN NY ACAD SCI                 93   500 962
   002   BANJO C               CANCER RES                      34  2114 974
   003   BIRD GWG              J MED GENET                     12   174 975
   004   BOAT TF               PEDIATR RES                      8   531 974
   005   BURTIN P              CANCER RES                      33  3299 973
   006   CONOVER JH            PEDIATR RES                      7   220 973
   007   DARCY DA              BR J CANCER                     28   147 973
   008   DAVIDSON AG           LANCET                           2  1393 973
   009   DI SANTAGNESE PA      N ENGL J MED                   277  1287 967
   010   DISCHE Z              PEDIATRICS                      24    74 959
   011   CAUDILL M             LANCET                           2   307 973
   012   ESTERLY NB            AM J DIS CHILD                 123   200 972
   013   GOLD P                J EXP MED                      121   439 965
   014   GOLD P                J EXP MED                      122   467 965
   015   HANSEN HJ             HUM PATHOL                       5   139 974
   016   LAMBLIN G             CLIN CHIM ACTA                  36   329 972
   017   LEV R                 AM J PATHOL                     46    23 965
   018   LOUISOT P             CLIN CHIM ACTA                  48   373 973
   019   MACH JP               IMMUNOCHEMISTRY                  9  1031 972
   020   MACSWEEN JM           BR J CANCER                     26   356 972
   021   MANDEL ID             AM J DIS CHILD                 113   431 967
   022   MANGIAROTTI-MARCHI MA MED CHIR DIG                     3   141 974
   023   MANGOS JA             SCIENCE                        158   135 967
   024   MANGOS JA             PEDIATR RES                      1   436 967
   025   MARTIN F              INT J CANCER                     6   352 970
   026   MCCOMBS ML            TEX REP BIOL MED                31   615 973
   027   NEVILLE AM            INT J CANCER                    14     1 974
   028   POTTER JL             ANN NY ACAD SCI                106   692 963
   029   RENNERT OM            ANN CLIN LAB SCI                 3     1 973
   030   ROELFS RE             AM J DIS CHILD                 113   419 967
   031   ROGALSKY VY           LANCET                           1  1322 973
   032   ROUSSEL P             J BIOL CHEM                    250  2114 975
   033   SHWACHMAN H           IN: KENDIG EL JR                     541 967
   034   VONKLEIST S           PROC NAT ACAD SCI USA           69  2492 972
   036   WILSON GB             PEDIATR RES                      9   635 975
   037   WOOD RE               AM REV RESPIR DIS              113   833 976
   038   ZANCHECK Z            N ENGL J MED                   286    83 972
CT   1   WILSON GB             PEDIATR RES                     11   986 977
     2   WILSON GB             NATURE                         266   463 977
     3   WILSON GB             PEDIATR RES                     12   801 978
     4   ALHADEFF JA           CLIN GENET                      14   189 978
     5   MACSWEEN JM           PEDIATR RES                     14   187 980
     6   WILSON GB             CLIN GENET                      26   331 984